Transcranial Photobiomodulation for Depression, Anxiety, and PTSD - Lumaflex

Transcranial Photobiomodulation for Depression, Anxiety, and PTSD

Preventing Post-Traumatic Stress Disorder (PTSD) in rats with pulsed 810 nm laser transcranial phototherapy

Lumaflex Research Institute

Study Overview

Description:  This chapter reviews the potential of transcranial photobiomodulation (tPBM) as a therapeutic approach for major depressive disorder (MDD), anxiety disorders, and post-traumatic stress disorder (PTSD). It discusses the prevalence of these mental health issues and the limitations of current treatments.

Source: PubMed

Summary

Focus: The therapeutic potential of transcranial photobiomodulation for common mental health problems like depression, anxiety, and PTSD.

Intervention: Review of various tPBM studies and their findings related to different wavelengths and parameters used for these conditions. (Specific parameters like wavelength, frequency, etc., are not the primary focus of this review's summary, but rather the overall concept and findings across studies).

Methods: This is a comprehensive review synthesizing existing research on tPBM's application in mental health.

Conclusion

The chapter highlights the promise of transcranial photobiomodulation as a novel intervention for major depressive disorder, anxiety disorders, and PTSD, suggesting it offers a new therapeutic resource given the limitations of conventional treatments. (Specific details about "ideal frequencies" or precise wavelengths are dependent on the individual studies reviewed within the chapter, rather than being a conclusion of the chapter itself.)